Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Connolly

Showing results (481-490 of 491) with videos related to

Pageof 50
Sort By:
Journal of Neuro-Oncology|November 30, 2015
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgeryChristopher S Grubb, Ashish Jani, Cheng-Chia Wu, et al.
CNS Oncology|February 3, 2018
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastasesCheng-Hung Tai, Cheng-Chia Wu, Mark E Hwang, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2020
Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrasePrasanna Sivaprakasam, Zhongyu Wang, Nicholas A Meanwell, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological propertiesYasutsugu Ueda, John D Matiskella, Jerzy Golik, et al.
Journal of Neuro-Oncology|July 5, 2017
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis developmentAnurag Saraf, Christopher S Grubb, Mark E Hwang, et al.
Future Oncology (London, England)|June 27, 2025
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancerLior Z Braunstein, Melissa P Mitchell, Hanna Bandos, et al.
Human Reproduction Open|May 3, 2024
Current global status of male reproductive healthChristopher J De Jonge, Christopher L R Barratt, R John Aitken, et al.
Kidney International Reports|November 9, 2020
Pilot Randomized Controlled Trial of a Standard Versus a Modified Low-Phosphorus Diet in Hemodialysis PatientsFiona N Byrne, Barbara A Gillman, Mairead Kiely, et al.
Annals of Surgical Oncology|July 24, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 23, 2025
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Pageof 50

Showing results (481-490 of 491) with videos related to

Sort By:
Pageof 50
Journal of Neuro-Oncology|November 30, 2015
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgeryChristopher S Grubb, Ashish Jani, Cheng-Chia Wu, et al.
CNS Oncology|February 3, 2018
Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastasesCheng-Hung Tai, Cheng-Chia Wu, Mark E Hwang, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2020
Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrasePrasanna Sivaprakasam, Zhongyu Wang, Nicholas A Meanwell, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological propertiesYasutsugu Ueda, John D Matiskella, Jerzy Golik, et al.
Journal of Neuro-Oncology|July 5, 2017
Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis developmentAnurag Saraf, Christopher S Grubb, Mark E Hwang, et al.
Future Oncology (London, England)|June 27, 2025
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancerLior Z Braunstein, Melissa P Mitchell, Hanna Bandos, et al.
Human Reproduction Open|May 3, 2024
Current global status of male reproductive healthChristopher J De Jonge, Christopher L R Barratt, R John Aitken, et al.
Kidney International Reports|November 9, 2020
Pilot Randomized Controlled Trial of a Standard Versus a Modified Low-Phosphorus Diet in Hemodialysis PatientsFiona N Byrne, Barbara A Gillman, Mairead Kiely, et al.
Annals of Surgical Oncology|July 24, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 23, 2025
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Pageof 50